TASLY GROUP

TASLY GROUP

Company Background

TASLY is a chinese owned pharmaceutical company creating health and achieving future by selling its products through the multi level strategies.


The products are so efficient in such a way that even the USA FDA gives approval to their usage in USA and WHO has given credit to them, the international standardization etc have given full support and credit to our products.

** Listed in the international stock exchange in China - A class stock/First class

** Top Modern Traditional Chinese Medicine (TCM) company in China and rank at the top among more that 6000 TCM manufacturers in China.

** There are more that 10,000 hospitals around the world using TASLY Products.

** Practicing 6 G's - GAP, GMP, GLP, GEP, GCP, GSP.

** Over 100million worldwide consumers including America, Africa France, Rusia, Indonesia, Singapore, Malaysia etc.

** Awards and achievements - FDA, GMP, ISO 9001/4001, OSHMS, TGS, Halal Certificate from JAKIM and approved by Ministry of Health Malaysia.



TASLY(M) SDN BHD

TASLY MALAYSIA was established in March 2004 with Capital of RM5 Million.


Please leave your contact detail if you interested to join TASLY. We will contact back A.S.A.P

Membership Form

Success Nite

Success Nite

Malam Anugerah (Seremban NS)

Tuesday, October 14, 2008

Danshen Plus Capsule

Danshen Plus have the Ultimate Solution for you.....
It improves blood circulations flow. Poor Circulation is the cause of all disease. Scientifically proven to prevent microcirculation problems. Will help to fight and prevent these diseases....

1. Heart Disease
2. Diabetes
3. High Blood Preasure
4. Stroke
5. Liver-fire
6. Migraine
7. Hypertension
8. Cancer

  • Prevents coronary heart disease (CHD)
  • Cleans blood vessels and protects the 2nd heart; microcirculation
  • Improve diabetic-related eye disease and dysfunction of kidneys
  • Protects from stroke
  • protects liver cells
  • lower blood lipid and reduce plaque from atherroclerosis


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)